triple antiplatelet therapy
The clinical outcomes of triple antiplatelet therapy versus dual antiplatelet therapy for high-risk patients after coronary stent implantation: a meta-analysis of 11 clinical trials and 9,553 patients
... “triple antiplatelet therapy”, “TAPT”, “dual anti- platelet therapy”, “DAPT”, “acute myocardial infarction or AMI”, “acute coronary syndrome or ACS”, “chronic total occlusion”, “left main”, ...
14
Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis
... compared triple antiplatelet therapy with dual therapy (Table ...additional antiplatelet agent (no studies used an oral GP IIb/IIIa receptor antagonist, presumably because of hazard ...
14
Original Article Clinical efficacy of triple antiplatelet therapy with tirofiban in elderly patients with acute coronary syndrome
... of triple antiplatelet therapy (TAT) with tirofiban in treatment of elderly patients with acute coronary syndrome ...duel antiplatelet therapy (DAT) with aspirin plus clopidogrel, while ...
6
TRIPLE ANTIPLATELET THERAPY AND INCIDANCE OF DRUG RESISTANCE
... to antiplatelet drugs is associated with subsequent major adverse clinical ...for triple antiplatelet therapy in comparison of dual antiplatelet ...with triple (aspirin, ...
9
Sarpogrelate Based Triple Antiplatelet Therapy Improved Left Ventricular Systolic Function in Acute Myocardial Infarction: Retrospective Study
... Primary PCI was performed according to standard techniques. Before the index procedure, all patients received 300 mg of as- pirin and 600 of mg clopidogrel as loading doses. Among them, 53 patients received additional ...
9
Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention
... Previous studies of antithrombotic strategy in patient who underwent PCI focused mostly on bivalirudin or triple- antiplatelet therapy after PCI. The ISAR-REACT 3 trial had shown that although ...
5
Recurrent posterior circulation infarction caused by anomalous occipital bony process in a young patient
... and triple antiplatelet therapy, we decided to perform endovascular occlusion of the left vertebral artery by ...4). Triple antiplatelet therapy was continued for 5 months and ...
5
Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysis
... newer antiplatelet treatment strategies have been used in patients with coronary artery disease ...dual antiplatelet therapy (DAPT) consisting of aspirin and clopidogrel, double dose clopidogrel ...
11
Safety and efficacy of intensive vs guideline antiplatelet therapy in high risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)
... dual therapy is more effective at preventing recurrence than monotherapy for acute prophylaxis, then intensive therapy with triple antiplatelets (combined aspirin + clopidogrel + dipyrida- mole) may ...
7
Clinical potential of vorapaxar in cardiovascular risk reduction in patients with atherosclerosis
... of triple antiplatelet therapy in patients with particularly high ischemic ...between triple antiplatelet therapy with ASA, clopidogrel, and vorapaxar – and triple ...
6
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
... ing was higher in the antiplatelet group than in the antico- agulant group (2.4% versus 0.4%, P = 0.06) [85]. Also, in the ISAR trial, the antiplatelet regimen became superior only after 3 days of treatment ...
12
Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics
... for antiplatelet and anticoagulation therapeutics, given the increasing body of evidence implicating genetic variation in variable drug ...used antiplatelet (ie, clopidogrel and aspirin) and anticoagulation ...
19
Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor
... of therapy (no difference at 30 days) and increased serum uric acid and serum creatinine from baseline, which remained different throughout the study duration, but were no longer different 1 month after study drug ...
23
Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?
... After undergoing upper endoscopies, patients in Group A were immediately prescribed pantoprazole 40 mg 2×/ day, amoxicillin 1000 mg 12/12 h and CLARI 500 mg 12/12 h, for 14 days. Patients in Group B were pre- scribed ...
8
Proteinase-activated receptors (PARs) as targets for antiplatelet therapy
... Dual antiplatelet therapies (aspirin and the P2Y12 receptor inhibitor Clopidogrel) are commonly prescribed to ACS patients to minimize cardiovascular events such as thrombosis however not all patients tolerate ...
12
<p>Simvastatin improves the eradication rate of <em>Helicobacter pylori</em>: upper Egypt experience</p>
... Helicobacter pylori colonizes the gastric mucosa, leading to gastritis, peptic ulcer disease, 2,3 gastric adenocarcinoma, 4,5 and type B low-grade mucosal-associated lymphoma. 6 Also, many extra-digestive diseases are ...
6
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
... dual antiplatelet therapy with ASA and thienopyridines (ticlopidine or clopido- grel) is limited by the variability in the antiplatelet response ...to antiplatelet therapy to an ...
12
DENTAL MANAGEMENT OF PATIENTS ON ANTIPLATELET THERAPY: LITERATURE UPDATE
... on antiplatelet drugs ...aspirin therapy and recommend not to stop antiplatelet drugs before tooth extraction and that the hemostasis method is ...dual antiplatelet therapy, undergoing ...
6
<p>The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials</p>
... inhaler triple therapy, including FF/UMEC/VI, BDP/FOR/GB, and BUD/GB/FOR, with other treatment options for patients with COPD were included in the meta- ...dual therapy and ICS/LABA plus LAMA ...
10
Incidence of Microemboli and Correlation with Platelet Inhibition in Aneurysmal Flow Diversion
... dual antiplatelet medications (aspirin, 325 mg, and clopidogrel, 75 mg daily, ex- cept 1 patient who was switched from clopidogrel to prasugrel, 10 mg daily, due to gastrointestinal ...
5